Clinical trial
A Phase II Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.
NCT03845387 is registered in ClinicalTrials.gov with Kissei Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.
- Lead sponsor
- Kissei Pharmaceutical Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 26, 2019
- Completion date
- February 21, 2020
- Enrollment
- 74 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.